What good is color vision in the dark of the deep sea? For some crabs, an ability to see blue and ultraviolet light may mean the difference between chowing down on a good meal versus a toxic one.
A new study published in the Journal of Experimental Biology finds that some seafloor, or benthic, crabs can see in color. But the crustaceans live in darkness of the deep Caribbean where sunlight does not penetrate, making their sensitivity to blue and ultraviolet light mysterious.
(Source: livescience.com)
Filed under color vision neuroscience ocean vision UV vision evolution science
This month, in honor of National Women’s Health and Fitness Day on September 26th, we’ll be exploring upcoming and previously published work in PLOS ONE surrounding this topic. The breadth of this subject is wide and, sure, we could probably start a whole new blog just to discuss PLOS ONE articles about women’s health, but instead we’ve created a bite-sized series that will highlight a few important issues, including cardiovascular health, anorexia, pregnancy, and ovarian cancer.
Filed under articles health neuroscience psychology women fitness science
Scientists have found that one gene is responsible for variability in locomotion in horses and mice.
Traits such as height are controlled by the interaction of up to 700 genes. So it came as quite a shock to researchers from Uppsala University (UU) and their international collaborators that the mutation of just a single gene is responsible for variability in locomotion in horses and mice. Furthermore, the research team discovered that this gene, DMRT3, is expressed in a previously unknown set of neurons in the spinal cord. These findings provide insight into the neural circuits that coordinate movement in vertebrates.
“The amazing result was that we found one very strong signal on one chromosome which by further work led to the discovery of the DMRT3 mutation,” explains Leif Andersson, co-author of the paper published in Nature, from UU and Swedish University of Agricultural Sciences. “This was unexpected since we had [anticipated] a much more complex genetic background for a trait like this.”
Filed under vertebrates neuroscience neuron genetics DMRT3 psychology science
Half a dozen times each night, your slumbering body performs a remarkable feat of coordination.
During the deepest throes of sleep, the body’s support systems run on their own timetables. Nerve cells hum along in your brain, their chitchat generating slow waves that signal sleep’s nether stages. Yet, like buses and trains with overlapping routes but unsynchronized schedules, this neural conversation has little to say to your heart, which pumps blood to its own rhythm through the body’s arteries and veins. Air likewise skips into the nostrils and down the windpipe in seemingly random spits and spats. And muscle fluctuations that make the legs twitch come and go as if in a vacuum. Networks of muscles, of brain cells, of airways and lungs, of heart and vessels operate largely independently.
Every couple of hours, though, in as little as 30 seconds, the barriers break down. Suddenly, there’s synchrony. All the disjointed activity of deep sleep starts to connect with its surroundings. Each network — run via the group effort of its own muscular, cellular and molecular players — joins the larger team.
This change, marking the transition from deep to light sleep, has only recently been understood in detail — thanks to a new look at when and how the body’s myriad networks link up to form an übernetwork.
Read more
Filed under bodily function brain interconnected systems networks neuroscience psychology networks of networks science
This week, a strategic roadmap to help to the nation’s health care system cope with the impending public health crisis caused Alzheimer’s disease and related dementia will be published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. The plan aims to link the latest scientific findings with clinical care and bring together patients, families, scientists, pharmaceutical companies, regulatory agencies, and advocacy organizations behind a common set of prioritized goals. The consensus document is the outcome of a June meeting of leading Alzheimer’s researchers, advocates and clinicians, who gathered as part of the Marian S. Ware Alzheimer Program at the University of Pennsylvania.
Today, 5.4 million people are living with the disease, and more than 15 million Americans are caring for persons with Alzheimer’s and other dementias, according to the Alzheimer’s Association. Alzheimer’s disease is the sixth-leading cause of death in the United States and the only cause of death among the top 10 in the United States that cannot be prevented, cured, or even slowed.
"Our plan aims to provide good quality care for affected patients and families, advance our understanding of the pathophysiology and natural history of AD and other dementias, develop effective treatments to slow or prevent these diseases, and translate scientific advances successfully into policy and practice," the authors wrote.
(Source: nursing.upenn.edu)
Read more …
Filed under alzheimer alzheimer's disease brain neuroscience psychology science
Mothers aren’t the only ones who are biologically adapted to respond to children. New research from the University of Notre Dame shows that dads who sleep near their children experience a drop in testosterone. Previous research from humans and other species suggests this decrease might make men more responsive to their children’s needs and help them focus on the demands of parenthood.
Filed under parenthood fatherhood testosterone neuroscience psychology science
New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.
The findings appeared online Sept. 4 in the Proceedings of the National Academy of Sciences, and is the result of a study from scientists at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health.
“Many promising drugs fail because they cannot cross the blood-brain barrier sufficiently to provide a therapeutic dose to the brain,” said David Miller, Ph.D., head of the Laboratory of Toxicology and Pharmacology at NIEHS, and leader of the team that performed the study. “We hope our new strategy will have a positive impact on people with brain disorders in the future.”
In a two-pronged approach, the research team first determined that treating rat brain capillaries with the multiple sclerosis drug marketed as Gilenya (fingolimod) stimulated a specific biochemical signaling pathway in the blood-brain barrier that rapidly and reversibly turned off P-glycoprotein. Team members then pretreated rats with fingolimod, and administered three other drugs that P-glycoprotein usually transports away from the brain. They observed a dramatic decline in P-glycoprotein transport activity, which led to a threefold to fivefold increase in brain uptake for each of the three drugs.
Ronald Cannon, Ph.D., is a staff scientist in the Miller lab and first author on the paper. He said one of the burning questions the team wants to tackle next is to understand how the signaling system turns off P-glycoprotein. He equates the mechanism to what happens when a person flips a light switch.
“If you physically turn off a light using the button on the wall, the light will go out because the electrical current to the light bulb has been interrupted,” Cannon explained. “But what happens when the signaling pathway shuts down P-glycoprotein? Does it bring in another protein to bind to the pump, take away its energy source, modify the structure of the pump, or something else?”
Cannon said the paper’s findings open a new way of thinking regarding targets for drug design, a thought that is emotionally gratifying for him and many other researchers whose scientific discoveries generally don’t directly translate into helping people with illnesses.
“Although much more research needs to be done, delivering therapeutics to the central nervous system is one of the final frontiers of pharmacotherapy, Cannon added.”
(Source: niehs.nih.gov)
Filed under brain drugs medicinal drugs neuroscience brain disorders psychology science
Study finds new benefit of coffee: It reduces pain
The surprising finding is based on a study involving 48 volunteers who agreed to spend 90 minutes performing fake computer tasks meant to mimic office work. The tasks were known to cause pain in the shoulders, neck, forearms and wrists, and the researchers wanted to compare how people with chronic pain and those who were pain-free tolerated the tasks.
As a matter of convenience, the scientists allowed people to drink coffee before taking the test “to avoid unpleasant effects of caffeine deprivation, e.g. decreased vigor and alertness, sleepiness, and fatigue,” they reported.
But when it came time to analyze the data, the researchers from Norway’s National Institute of Occupational Health and Oslo University Hospital noticed that the 19 people who drank coffee reported a lower intensity of pain than the 29 people who didn’t.
In the shoulders and neck, for instance, the average pain intensity was rated 41 (on a 100-point scale) among the coffee drinkers and 55 for the coffee abstainers. Similar gaps were found for all pain sites measured, and coffee’s apparent pain-mitigation effect held up regardless of whether the subjects had chronic pain or not.
The authors of the study, which was published this week in the journal BMC Research Notes, cautioned that since the study wasn’t designed to test coffee’s influence on pain, the results come with many uncertainties. For starters, the researchers don’t know how much coffee the coffee drinkers consumed before taking the computer tests. They also doubt that the coffee drinkers and abstainers were similar in all respects except for their java consumption. Problems like these tend to undermine the importance of the findings. But those reservations are unlikely to trouble the legions of coffee drinkers looking for any reason not to cut back on their daily caffeine habit.
Filed under caffeine neuroscience brain psychology pain science
Have you ever noticed how tiresome it can be to follow a conversation at a noisy party? Rest assured: this is not necessarily due to bad hearing – although that might make things worse. Scientists at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig have found that adverse listening situations are difficult for the brain, partly because they draw on the same, limited resources supporting our short-term memory. The new findings are particularly relevant to understanding the cognitive consequences of hearing damage, a condition that affects an increasing number of people.
Filed under memory STM neuroscience brain psychology noise hearing
Brain Networks of Explicit and Implicit Learning
Are explicit versus implicit learning mechanisms reflected in the brain as distinct neural structures, as previous research indicates, or are they distinguished by brain networks that involve overlapping systems with differential connectivity? In this functional MRI study we examined the neural correlates of explicit and implicit learning of artificial grammar sequences. Using effective connectivity analyses we found that brain networks of different connectivity underlie the two types of learning: while both processes involve activation in a set of cortical and subcortical structures, explicit learners engage a network that uses the insula as a key mediator whereas implicit learners evoke a direct frontal-striatal network. Individual differences in working memory also differentially impact the two types of sequence learning.
Filed under brain neuroscience psychology learning learning mechanisms explicit implicit science
![Scientists have found that one gene is responsible for variability in locomotion in horses and mice.
Traits such as height are controlled by the interaction of up to 700 genes. So it came as quite a shock to researchers from Uppsala University (UU) and their international collaborators that the mutation of just a single gene is responsible for variability in locomotion in horses and mice. Furthermore, the research team discovered that this gene, DMRT3, is expressed in a previously unknown set of neurons in the spinal cord. These findings provide insight into the neural circuits that coordinate movement in vertebrates.
“The amazing result was that we found one very strong signal on one chromosome which by further work led to the discovery of the DMRT3 mutation,” explains Leif Andersson, co-author of the paper published in Nature, from UU and Swedish University of Agricultural Sciences. “This was unexpected since we had [anticipated] a much more complex genetic background for a trait like this.”](http://33.media.tumblr.com/tumblr_ma13qp01ib1rog5d1o1_500.gif)
